Astrazeneca to begin Phase 1/2 clinical trials of coronavirus vaccine in Japan - (Yahoo!Finance via NewsPoints Desk)

  • AstraZeneca said it is beginning Phase I/II clinical trials of its COVID-19 vaccine candidate in Japan, as reported in Yahoo!Finance. 

  • The trials of the vaccine AZD1222 will be conducted at multiple facilities in the country and target 250 subjects.

  • The company is working with Daiichi Sankyo and JCR Pharma in Japan to make and distribute the vaccine. 

To read more NewsPoints articles, click here.